NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 98 / 982

  1. Decreased Effectiveness of a Novel Opioid Withdrawal Protocol Following the Emergence of Medetomidine as a Fentanyl Adulterant2025 · OpenAlex
  2. Decreases in serum α-Klotho levels in association with levels of regular alcohol drinking and binge drinking among US adults2025 · Crossref
  3. Decreasing Preoperative Anxiety in Patients with Newly Available Multimodal Approaches—A Narrative Review2025 · OpenAlex
  4. Decriminalization of cannabis use in South Africa: The perspectives and health outcomes among medical students; A systematic qualitative review2025 · Crossref
  5. Decriminalization of medical hashish use for the treatment of epilepsy patients in indonesia2025 · OpenAlex
  6. Deep Transcranial Magnetic Stimulation in Patients With Opioid Use Disorder: A Double‐Blind, Placebo‐Controlled Randomized Trial2025 · Crossref
  7. Deficits in Alcohol Enforcement Legislation in Ireland: Bottomless Brunches2025 · Crossref
  8. Defining terminology and outcome measures for evaluating overdose response technology: An international Delphi study2025 · OpenAlex
  9. Delinquent Adolescents’ Substance Use during Stay in Juvenile Correctional and Rehabilitation Center2025 · Crossref
  10. Delphi consensus methodology to gauge expert perspectives on smoking prevention, cessation and harm reduction in Italy2025 · Crossref
  11. Demographic and clinical predictors of response and remission in the treatment of major depressive disorder with ketamine and esketamine: A systematic review2025 · OpenAlex
  12. Demographic determinants of drug addiction in Algerian society An analytical statistical study based on data from the National Office for the Fight against Drugs and Drug Addiction (2012–2022)2025 · Crossref
  13. Demographic Predictors of Medicinal Cannabis Users' Perceived Level of Physician Support for Medicinal Cannabis Prescriptions in New Zealand2025 · Crossref
  14. Demographic, economic, and social status and knowledge of medical and alternative cannabis use among Northeastern Thai citizens: a case study of outpatients at community hospitals along the Thai–Cambodian border2025 · Crossref
  15. Demographic, Socioeconomic, and Clinical Variables Associated With Nonmedical Pharmaceutical Opioid Use and Heroin Use Among US Adults in 2021 to 20222025 · Crossref
  16. Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor2025 · OpenAlex
  17. Dendritic Pillar[6]Arenes with Fixed Planar Chirality for Stereoselective Inclusions in Water: A Case of Facile Differentiation of Cocaine Adulterants, Levamisole and Dexamisole2025 · OpenAlex
  18. Density Functional Theory in Forensic Science: Applications and Challenges2025 · Crossref
  19. Depersonalisation-derealisation as a transdiagnostic treatment target: a scoping review of the evidence in anxiety, depression, and psychosis2025 · OpenAlex
  20. DEPRESSION AMONG PATIENTS WITH SUBSTANCE USE DISORDER IN A REHABILITATION PSYCHIATRY UNIT: A STUDY FROM KHYBER TEACHING HOSPITAL, PESHAWAR2025 · Crossref
  21. Depression among the ageing population of Ghana: The risk factors2025 · Crossref
  22. Depression and Alcohol Drinking Behavior: Association and Sex Differences Among Brazilian Adults2025 · Crossref
  23. Depression and Fitness: The Role of Psychopharmacology2025 · Crossref
  24. Depression Predicts Substance Use among Forcibly Displaced Migrants: A Quantitative Study among Refugees Living in Mbarara City, Southwestern Uganda2025 · OpenAlex
  25. Depressão Resistente: O papel da cetamina e psicodélicos2025 · OpenAlex
  26. Desarrollo profesional docente y práctica reflexiva en una unidad educativa pública de la ciudad del Coca2025 · Crossref
  27. Descriminalização do uso próprio de drogas: artigo 28 da lei de drogas2025 · Crossref
  28. Descripción de plantas psicoactivas2025 · OpenAlex
  29. Description and evaluation of a national humanitarian opioid poisoning education and naloxone distribution program2025 · OpenAlex
  30. Description and Evaluation of Practice-Based Training in OUD Care for Hospital-Based Generalist Physicians2025 · Crossref
  31. Desde una perspectiva actual: metanfetaminas y cannabis, una comparativa en la salud mental sobre el inicio de la esquizofrenia como complicación del consumo crónico. Revisión narrativa2025 · Crossref
  32. Deserved or Undeserved? Paranoia Subtypes as Predictors of Internalized Stigma in Schizophrenia2025 · Crossref
  33. DESIGN AND CHARACTERIZATION OF A BILAYER SODIUM ALGINATE/CARBOXYMETHYL CELLULOSE PATCH ENRICHED WITH CANNABIDIOL AND ACTIVATED CARBON FOR POTENTIAL USE IN ACNE TREATMENT2025 · OpenAlex
  34. Design and Development of Constructivist-Based Teaching Materials for Khat and Rasm to Improve Arabic Writing and Reading Skills2025 · Crossref
  35. Design and Evaluate Polymeric Micelles Loaded with Paclitaxel, A Chemotherapy Drug, for Breast Cancer Treatment2025 · Crossref
  36. Design and Production of an Instant Coffee Product Based on Greek Coffee Oil: Study of the Effect of Storage Conditions on Product Aroma and Quality2025 · Crossref
  37. Design and Validation of an Addiction Potential Questionnaire for Iranian Children Aged 12 to 18 Using Exploratory Factor Analysis2025 · Crossref
  38. Design of a cluster-randomized, hybrid type 1 effectiveness-implementation trial of a care navigation intervention to increase substance use disorder treatment engagement: study protocol2025 · Crossref
  39. Design of a Nutraceutical Gummy Candy Incorporating Hydrolysed Hemp (Cannabis sativa L.) as an Antioxidant and Antihypertensive Ingredient2025 · Crossref
  40. Design Workgroups: An Approach to Adapting Evidence-Based Health Interventions2025 · Crossref
  41. Design, Synthesis, and Pharmacological Evaluation of Piperazine Hydrazide Derivatives as Potential CNS-Active Antidepressants: MAO-A Inhibition and In Silico Docking Studies on Protein 2BXR and N1 Neuraminidase (PDB 2HU4) for Alzheimer's Disease2025 · OpenAlex
  42. Designer benzodiazepines: Availability, motives, and fatalities. A systematic narrative review of human studies2025 · OpenAlex
  43. Designing behavioural change intervention module for tobacco cessation counselling among pregnant tobacco users in India: a methodology paper2025 · Crossref
  44. Designing Better Drug Regulation: Lessons from Policy Design Methods2025 · Crossref
  45. Designing NUDGE-based interventions for people with excess alcohol drinking: a proof of concept study2025 · Crossref
  46. Designing Religiously Informed and Culturally Acceptable Tobacco Cessation Interventions for UK-Based Muslims2025 · Crossref
  47. Desirable treatment or a problematic drug scene? – An interview study of patients’ and professionals’ views on the risks and benefits of liberalized opioid agonist treatment2025 · Crossref
  48. Destigmatizing Cannabis: A Theoretical Exploration of Shifting Consumption Norms in the U.S. Legal Market2025 · Crossref
  49. Desvendando mecanismos antidepressivos de ervas medicinais2025 · OpenAlex
  50. Detecting and understanding potential stigma among medical cannabis users in Germany2025 · Crossref
  51. Detecting cannabis use reduction through biochemical verification of urinary cannabinoids: An aggregated analysis of cannabis use disorder treatment trials examining average reductions and individual cut‐points2025 · Crossref
  52. Detection and quantification of drugs on banknotes by LC–MS/MS with a fast and non-destructive sample preparation: a comparison of three cities2025 · Crossref
  53. Detection and quantitation of the semi-synthetic cannabinoid hexahydrocannabinol in seized samples from Scottish prisons2025 · OpenAlex
  54. Detection of Abiotic Stress in Potato and Sweet Potato Plants Using Hyperspectral Imaging and Machine Learning2025 · Crossref
  55. Detection of Adulterants in Herbal Weight Loss Supplements2025 · OpenAlex
  56. Detection of benzodiazepines in the unregulated drug supply using point of care and confirmatory drug checking technologies: A validation study2025 · OpenAlex
  57. Detection of dissociative states in patients during the administration of Es-ketamine by monitoring with the Dissociative Experience Scale II (DES II) - Part I2025 · Crossref
  58. Detection of ketamine in the oral fluid of drivers in northeastern France during the years 2020–20232025 · OpenAlex
  59. Detection of Metabolites of the New Synthetic Cannabinoid MDMB-4en-PINACA in Human Urine by Liquid and Gas Chromato-Mass Spectrometry Methods2025 · Crossref
  60. Determinants of COVID 19 Vaccine Uptake Among People with Substance Use Disorder in Türkiye2025 · Crossref
  61. Determinants of Readiness to Change among Treatment-seeking Patients with Substance Use Disorders in a Psychiatric Facility in Lagos State2025 · Crossref
  62. DETERMINANTS OF SUBSTANCE USE AMONG SECONDARY SCHOOL STUDENTS IN NYARUGENGE DISTRICT, RWANDA2025 · Crossref
  63. Determination of Flavonoids, Phenolic and Total Antioxidant Content from the Leaves, Stems and Roots of Betel Plants2025 · Crossref
  64. Determination of Germination and Emergence Performance of Hemp (Cannabis sativa L.) Seeds at Different Maturity Stages2025 · Crossref
  65. Determination of Mitragynine and 7‐Hydroxymitragynine in Raw Kratom Plant Material by a Multisegment Injection Capillary Zone Electrophoresis‐Tandem Mass Spectrometry2025 · Crossref
  66. Determination of Optimal Harvest Time in Cannabis sativa L. Based upon Stigma Color Transition2025 · Crossref
  67. Determination of Toxic Metals in Tobacco from Selected Imported Cigarette Brands and Local Tobacco in Iraqi Markets2025 · Crossref
  68. Determination of tramadol and its metabolite O-desmethyltramadol in vitreous humor. Is it helpful in forensic casework?2025 · Crossref
  69. Determination of volatile components in various extracts from wild chamomile (Matricaria chamomilla L.) flowers by gas chromatographic-mass spectrometry2025 · Crossref
  70. DETERMINAÇÃO DO TEOR DE ÓLEOS ESSENCIAIS EM CANNABIS SATIVA L. CULTIVADA NA ASSOCIAÇÃO TERAPÊUTICA CANNABIS MEDICINAL FLOR DA VIDA2025 · Crossref
  71. Determining the diagnostic cut-off on the Chinese version of severity of dependence scale for cannabis2025 · OpenAlex
  72. Determining the Effectiveness of Faith-Based Abstinence-Oriented Therapy on Self-Efficacy and Resilience in Individuals with Substance Use Disorder Under Treatment in Kerman2025 · Crossref
  73. Determining the Predictive Contribution of Addiction Readiness Based on Identity Styles with the Mediation of Self-Differentiation and Social Problem-Solving in Prisoners of Isfahan Province2025 · Crossref
  74. Developing a comprehensive inventory to define harm reduction housing2025 · Crossref
  75. Developing a Dialectical Behavior Therapy-Based Addiction Prevention Package for Adolescents: A Qualitative Study2025 · Crossref
  76. Developing a Health Campaign for Mental Health Awareness and Substance Use Prevention in Response to the COVID-19 Pandemic2025 · Crossref
  77. Developing a Mock Retail Cannabis Shop for Research: A Description of The CANNEX2025 · Crossref
  78. Developing a Pandemic-Related Mental Health Micro-Collection for an Academic Library2025 · OpenAlex
  79. Developing a scale to measure dissociation between self-states (the Dissociation-Integration of Self States Scale, D-ISS Scale)2025 · Crossref
  80. Developing a sentinel network for illicit substance use monitoring in Spain: a qualitative approach to key determinants2025 · Crossref
  81. Developing a smartphone-based training strategy for tobacco control in India: a formative study using consolidated framework for implementation research2025 · Crossref
  82. Developing a theory-based health education intervention to prevent adolescent students from smokeless tobacco use2025 · Crossref
  83. Developing a translational research framework for MDD: combining biomolecular mechanisms with a spiraling risk factor model2025 · OpenAlex
  84. Developing an Algorithm for Temporary Bans on New Psychoactive Substances: A Delphi Consensus Study2025 · Crossref
  85. Developing an Inpatient Substance Use Disorder Program in a Middle-Income Country: The Experience of Sbrana Psychiatric Hospital, Botswana2025 · Crossref
  86. Developing and testing a digital harm reduction app for GBMSM engaging in chemsex: a feasibility study grounded in users' lived experiences2025 · Crossref
  87. Developing Medical Cannabis Competencies2025 · OpenAlex
  88. Development and Delivery of a Theory-Guided Prescription Stimulant Misuse and Diversion Curriculum for College Health Providers: Results From Validity, Delphi, and Pre-Post Testing2025 · Crossref
  89. Development and Evaluation of a Family-Centered Psychological Intervention Program on Self-Worth in Women with Substance Use Disorder2025 · Crossref
  90. Development and Evaluation of Anti-inflammatory Multi-herbal Extract with Indigenous Medicinal Plants2025 · Crossref
  91. Development and Evaluation of Microcapsules Containing Combined Extracts of Bay, Cherry, and Green Betel Leaves as Natural Antioxidants2025 · Crossref
  92. Development and Implementation of a Substance Use Disorder eConsult2025 · Crossref
  93. Development and optimization of PFAS extraction in soil’s headspace followed by multidimensional gas chromatography and mass spectrometry2025 · Crossref
  94. Development and Piloting of a Scalable Training for Peer Recovery Specialists in an Evidence-Based Substance Use Intervention: Preliminary Implementation Outcomes2025 · Crossref
  95. Development and Preliminary Evaluation of a Morita Therapy Protocol for Addiction Treatment: A Holistic Approach to Substance Use Rehabilitation2025 · Crossref
  96. Development and validation of a HPLC-DAD method for determining the content of tryptamines in methanolic extracts of fruiting bodies of mushrooms belonging to species of the Psilocybe genus.2025 · PubMed
  97. Development and validation of a minimal SNP genotyping panel for the differentiation of Cannabis sativa cultivars2025 · OpenAlex
  98. Development and validation of an analytical method for the determination of select 4-position ring-substituted tryptamines in plasma by liquid chromatography-tandem mass spectrometry.2025 · PubMed
  99. Development and Validation of an HPLC–UV/PDA Method for the Determination of Cannflavins in Different Cannabis sativa Chemovars2025 · Crossref
  100. Development and Validation of Inductively Coupled Plasma Mass Spectrometry Method for Quantification of Lithium in Whole Blood from Forensic Postmortem Cases2025 · Crossref